HIV Care Continuum and Meeting 90-90-90 Targets: Cascade of Care Analyses of a U.S. Military Cohort.


Journal

Military medicine
ISSN: 1930-613X
Titre abrégé: Mil Med
Pays: England
ID NLM: 2984771R

Informations de publication

Date de publication:
14 08 2020
Historique:
received: 15 09 2019
revised: 01 11 2019
accepted: 31 01 2020
pubmed: 25 3 2020
medline: 4 3 2021
entrez: 25 3 2020
Statut: ppublish

Résumé

The new initiative by the Department of Health and Human Services (DHHS) aims to decrease new HIV infections in the U.S. by 75% within 5 years and 90% within 10 years. Our objective was to evaluate whether the U.S. military provides a good example of the benefits of such policies. We conducted an analysis of a cohort of 1,405 active duty military personnel with HIV enrolled in the Natural History Study who were diagnosed between 2003 and 2015 at six U.S. military medical centers. The study was approved by institutional review boards at the Uniformed Services University of the Health Sciences and each of the sites. We evaluated the impact of Department of Defense (DoD) HIV care policies, including screening, linkage to care, treatment eligibility, and combined antiretroviral therapy (cART) initiation on achieving viral suppression (VS) within 3 years of diagnosis. As a secondary outcome, we evaluated the DoD's achievement of UNAIDS 90-90-90 targets. Nearly all (99%) were linked to care within 60 days. Among patients diagnosed in 2003-2009, 77.5% (95% confidence intervals (CI) 73.9-80.6%) became eligible for cART within 3 years of diagnosis, 70.6% (95% CI 66.6-74.1%) overall initiated cART, and 64.2% (95% CI 60.1-68.0%) overall achieved VS. Among patients diagnosed in 2010-2015, 98.7% (95% CI 96.7-99.5%) became eligible for cART within 3 years of diagnosis, 98.5% (95% CI 96.4-99.4%) overall initiated cART, and 89.8% (95% CI 86.0-92.5%) overall achieved VS. U.S. military HIV policies have been highly successful in achieving VS goals, exceeding the UNAIDS 90-90-90 targets. In spite of limitations, including generalizability, this example demonstrates the feasibility of the DHHS initiative to decrease new infections through testing, early treatment, and retention in care.

Identifiants

pubmed: 32207528
pii: 5811177
doi: 10.1093/milmed/usaa021
pmc: PMC7429920
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1147-e1154

Subventions

Organisme : NICHD NIH HHS
ID : P2C HD050924
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Published by Oxford University Press on behalf of the Association of Military Surgeons of the United States 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

PLoS One. 2017 Jun 7;12(6):e0178953
pubmed: 28591161
Curr Opin HIV AIDS. 2016 Jan;11(1):102-8
pubmed: 26545266
AIDS Res Ther. 2010 May 27;7:14
pubmed: 20507622
AIDS Res Hum Retroviruses. 2014 May;30(5):409-15
pubmed: 24401026
MMWR Morb Mortal Wkly Rep. 2018 Mar 22;68(11):267-272
pubmed: 30897075
Lancet HIV. 2017 May;4(5):e223-e230
pubmed: 28153470
MMWR Morb Mortal Wkly Rep. 2018 May 25;67(20):569-574
pubmed: 29795080
JAMA. 2019 Mar 5;321(9):844-845
pubmed: 30730529
Am J Epidemiol. 2009 May 1;169(9):1124-32
pubmed: 19318615
N Engl J Med. 2011 Aug 11;365(6):493-505
pubmed: 21767103
Mil Med. 2019 Nov 1;184(Suppl 2):6-17
pubmed: 31778201
JAMA. 2013 Oct 16;310(15):1619-20
pubmed: 24129466

Auteurs

Andrew Anglemyer (A)

Department of Operations Research, Naval Postgraduate School, 1 University Circle, Monterey, CA 93943, USA.
Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand.

Noah Haber (N)

Carolina Population Center, University of North Carolina, 123 W Franklin St, Chapel Hill, NC 27516, USA.
Meta-Research Innovation Center at Stanford University, Stanford, California.

Adi Noiman (A)

Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Rd, Bethesda, MD 20852, USA.
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., 6720A Rockledge Dr, Bethesda, MD 20817, USA.

George Rutherford (G)

Prevention and Public Health Group, Epidemiology and Biostatistics, University of California San Francisco, 550 16th Street, Second Floor, San Francisco, CA 94158, USA.

Anuradha Ganesan (A)

Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Rd, Bethesda, MD 20852, USA.
Division of Infectious Diseases, Walter Reed National Military Medical Center, 8901 Rockville Pike, Bethesda, MD 20889, USA.

Jason Blaylock (J)

Division of Infectious Diseases, Walter Reed National Military Medical Center, 8901 Rockville Pike, Bethesda, MD 20889, USA.

Jason Okulicz (J)

Infectious Disease Service, Brooke Army Medical Center, 3551 Roger Brooke Dr. Fort Sam Houston, TX 78234, USA.

Ryan C Maves (RC)

Division of Infectious Diseases, Naval Medical Center San Diego, 34800 Bob Wilson Drive, San Diego CA, 92134, TX 78234, USA.

Tahaniyat Lalani (T)

Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Rd, Bethesda, MD 20852, USA.
Division of Infectious Diseases, Naval Medical Center Portsmouth, 620 John Paul Jones Cir, Portsmouth, VA 23708, TX 78234, USA.

Christina Schofield (C)

Division of Infectious Diseases, Madigan Army Medical Center, 9040A, Jackson Ave, Joint Base Lewis-McChord, WA 98431, TX 78234, USA.

James Mancuso (J)

Armed Forces Health Surveillance Branch, 7700 Arlington Boulevard, Suite 5101, Falls Church, VA 22042, USA.

Brian K Agan (BK)

Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Rd, Bethesda, MD 20852, USA.
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., 6720A Rockledge Dr, Bethesda, MD 20817, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH